EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients

Peer Review reports

Original Submission
21 May 2022	Submitted	Original manuscript
2 Nov 2022	Reviewed	Reviewer Report - Kirsty Loudon
2 May 2023	Reviewed	Reviewer Report - Research Square Reviewer 1
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
2 May 2023	Editorially accepted
11 May 2023	Article published	10.1186/s13063-023-07344-7

Back to article page